Rebecca Wu

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

258

H-Index

1

About

Dr. Rebecca Wu is a leading otolaryngologist–head and neck surgeon whose research has fundamentally reshaped the treatment landscape for early oropharynx cancer. Her most influential work, a landmark 2014 systematic review comparing transoral robotic surgery (TORS) to intensity-modulated radiotherapy (IMRT), has garnered over 258 citations and remains a cornerstone reference for clinicians weighing surgical versus radiation approaches. By rigorously synthesizing evidence from six major databases, Dr. Wu provided the first comprehensive comparative effectiveness analysis, demonstrating that both modalities offer comparable oncologic control while highlighting distinct differences in functional outcomes and toxicity profiles. This seminal contribution has directly informed clinical decision-making and sparked further prospective trials. Beyond this pivotal review, Dr. Wu’s broader research portfolio continues to advance minimally invasive surgical techniques and optimize patient selection for organ-preserving therapies. Her work has been instrumental in shifting the paradigm toward personalized, function-sparing treatment for head and neck cancer patients, earning her recognition as a thought leader in transoral surgery and radiation oncology integration. Dr. Wu’s scholarship exemplifies how rigorous systematic methodology can translate into tangible improvements in cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
258
Total Citations
258
Avg Citations/Paper
🏆 Most Cited Paper
A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review
258 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago